Literature DB >> 26214771

Mesenchymal stem cells ameliorate LPS-induced acute lung injury through KGF promoting alveolar fluid clearance of alveolar type II cells.

J-W Li1, X Wu.   

Abstract

OBJECTIVE: It has been shown that Mesenchymal stem cells (MSCs) could prevent or alleviate acute lung injury (ALI) when transplanted into lung; however, the mechanisms involved remains elusive. The study aimed to investigate the effect of MSCs in repairing alveolar fluid clearance (AFC) of alveolar type-II (AT-II) cells through paracrine factors.
MATERIALS AND METHODS: Keratinocyte growth factor (KGF) concentration in the supernatant of MSC culture medium was measured, and MSCs in lung after intravenous administration was traced. Next, MSCs transfected with or without KGF SiRNA were injected intravenously into LPS-induced ALI rats. Histological change and wet/dry ratio were determined. AT-II cells were co-cultured with MSCs under different experimental situations to analyze the variation of α1 and β1 subunits of Na+-K+-ATPase in AT-II cells.
RESULTS: LPS-induced ALI was characterized by the typical inflammatory infiltrates, interalveolar septal thickening and increased wet/dry ratio. MSC administration significantly reduced the injury, while MSCs with KGF knockdown did no show the same effect. In vitro study also confirmed that expressions of α1 and β1 subunit were up-regulated as impaired AT-II cells co-cultured with MSCs. Furthermore, expression of α1 subunit was down-regulated, while β1 subunit showed no apparent change as AT-II cells were co-cultured with MSCs that were transfected with KGF siRNA.
CONCLUSIONS: AFC was impaired by inflammation insult. MSCs-derived KGF reduced the impaired AFC through up-regulated α1 subunit but not β1 subunit, which might provide a novel therapeutic strategy for ALI.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26214771

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  17 in total

Review 1.  Protein Interactions at Endothelial Junctions and Signaling Mechanisms Regulating Endothelial Permeability.

Authors:  Yulia A Komarova; Kevin Kruse; Dolly Mehta; Asrar B Malik
Journal:  Circ Res       Date:  2017-01-06       Impact factor: 17.367

Review 2.  Therapeutic potential of mesenchymal stem/stromal cell-derived secretome and vesicles for lung injury and disease.

Authors:  Airan Liu; Xiwen Zhang; Hongli He; Li Zhou; Yoshifumi Naito; Shinji Sugita; Jae-Woo Lee
Journal:  Expert Opin Biol Ther       Date:  2019-11-18       Impact factor: 4.388

3.  Activation of Liver X Receptor Attenuates Oleic Acid-Induced Acute Respiratory Distress Syndrome.

Authors:  Zanmei Zhao; Dan Xu; Shuqiang Li; Bei He; Yixian Huang; Meishu Xu; Songrong Ren; Song Li; Hui Wang; Wen Xie
Journal:  Am J Pathol       Date:  2016-08-09       Impact factor: 4.307

4.  Differentiation of UC-MSCs into hepatocyte-like cells in partially hepatectomized model rats.

Authors:  Zheng Chen; Qiaoting Kuang; Xue-Jun Lao; Jie Yang; Weidong Huang; Dong Zhou
Journal:  Exp Ther Med       Date:  2016-07-26       Impact factor: 2.447

5.  Human mesenchymal stromal cells exert HGF dependent cytoprotective effects in a human relevant pre-clinical model of COPD.

Authors:  Helen Kennelly; Bernard P Mahon; Karen English
Journal:  Sci Rep       Date:  2016-12-06       Impact factor: 4.379

Review 6.  Off-label use of adipose-derived stem cells.

Authors:  Francesco Simonacci; Nicolò Bertozzi; Edoardo Raposio
Journal:  Ann Med Surg (Lond)       Date:  2017-10-25

7.  Placenta‑derived mesenchymal stem cells ameliorate lipopolysaccharide‑induced inflammation in RAW264.7 cells and acute lung injury in rats.

Authors:  Wen Yuan; Heng-Ya Song; Jie Xiong; Wan-Li Jiang; Gan-Jun Kang; Jie Huang; Song-Ping Xie
Journal:  Mol Med Rep       Date:  2020-06-15       Impact factor: 2.952

Review 8.  Molecular Mechanisms Responsible for Therapeutic Potential of Mesenchymal Stem Cell-Derived Secretome.

Authors:  Carl Randall Harrell; Crissy Fellabaum; Nemanja Jovicic; Valentin Djonov; Nebojsa Arsenijevic; Vladislav Volarevic
Journal:  Cells       Date:  2019-05-16       Impact factor: 6.600

Review 9.  Rationale for the clinical use of adipose-derived mesenchymal stem cells for COVID-19 patients.

Authors:  Christopher J Rogers; Robert J Harman; Bruce A Bunnell; Martin A Schreiber; Charlie Xiang; Fu-Sheng Wang; Antonio F Santidrian; Boris R Minev
Journal:  J Transl Med       Date:  2020-05-18       Impact factor: 5.531

10.  Comparative Analysis of Human Mesenchymal Stem Cells from Umbilical Cord, Dental Pulp, and Menstrual Blood as Sources for Cell Therapy.

Authors:  Huaijuan Ren; Yunxia Sang; Fengli Zhang; Zhaoqing Liu; Nianmin Qi; Yantian Chen
Journal:  Stem Cells Int       Date:  2016-01-10       Impact factor: 5.443

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.